U.S. markets closed
  • S&P Futures

    3,981.00
    +3.00 (+0.08%)
     
  • Dow Futures

    32,336.00
    +17.00 (+0.05%)
     
  • Nasdaq Futures

    12,856.25
    +2.25 (+0.02%)
     
  • Russell 2000 Futures

    1,737.60
    +5.10 (+0.29%)
     
  • Crude Oil

    69.40
    -0.56 (-0.80%)
     
  • Gold

    1,996.10
    +0.20 (+0.01%)
     
  • Silver

    23.22
    -0.04 (-0.18%)
     
  • EUR/USD

    1.0833
    -0.0004 (-0.03%)
     
  • 10-Yr Bond

    3.4060
    -0.0940 (-2.69%)
     
  • Vix

    22.61
    +0.35 (+1.57%)
     
  • GBP/USD

    1.2278
    -0.0010 (-0.08%)
     
  • USD/JPY

    130.4070
    -0.3820 (-0.29%)
     
  • Bitcoin USD

    28,225.91
    +871.87 (+3.19%)
     
  • CMC Crypto 200

    617.36
    +19.90 (+3.33%)
     
  • FTSE 100

    7,499.60
    -67.24 (-0.89%)
     
  • Nikkei 225

    27,349.93
    -69.68 (-0.25%)
     

Moderna raises full-year COVID vaccine sales forecast to $21 billion

March 24 (Reuters) - Moderna Inc on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion.

The company in February forecast sales of $19 billion from its signed contracts, and option for $3 billion in additional purchases.

Moderna on Thursday forecast additional purchases of roughly $500 million. (Reporting by Manas Mishra in Bengaluru)